As the GEN article “Prospects for Downstream Production” notes, perfusion cell culture is most often associated with upstream continuous processing operations. The two main perfusion techniques are ...
Flagship iCELLis platform reportedly enables Phase III-scale production in laboratory-style facilities. Semiconductor materials and products firm ATMI has acquired Belgian biotech Artelis, which ...
In collaboration with Pall Corportion, biotech company Freeline completed the first full-scale run at its newly commissioned, GMP gene-therapy manufacturing facility in the UK. On April 29, 2019, Pall ...
LONDON--(BUSINESS WIRE)--There has been a growing demand for single-use bioreactors in recent years as single-use bioreactors are easy to use and can be easily set up for continuous processing. Single ...
DANBURY, Conn., Nov. 2, 2010 (GLOBE NEWSWIRE) -- ATMI, Inc. (Nasdaq:ATMI), announced today it has acquired the Belgian biotechnology firm Artelis S.A., an innovator in the area of highly-efficient ...
A recent industry survey shows keen interest in improving bioreactors and cell-culture media. Large-scale biopharmaceutical manufacturing equipment for upstream product manufacture has changed ...
LONDON--(BUSINESS WIRE)--Technavio has been monitoring the global bioreactors market and the market is poised to grow by USD 1.07 billion during 2019-2023 at a CAGR of almost 7% during the forecast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback